NeuBase Therapeutics, Inc.

  • ABOUT US
  • TECHNOLOGY
  • PIPELINE
  • PATIENTS
  • PARTNERING
  • INVESTORS
  • CONTACT US

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts
May 12, 2022 5:00pm EDT

NeuBase Therapeutics Reports Business Update and Financial Results for the Second Quarter of Fiscal Year 2022

May 02, 2022 4:30pm EDT

NeuBase Therapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2022 Annual Meeting

Mar 13, 2022 7:00pm EDT

NeuBase Therapeutics Presents New Preclinical Data at MDA 2022 for Its Myotonic Dystrophy Type 1 Program Demonstrating Splice Rescue, Nuclear Aggregate Resolution, and Myotonia Reversal

Mar 07, 2022 8:00am EST

NeuBase to Present at Oppenheimer’s 32nd Annual Healthcare Conference

Feb 28, 2022 8:00am EST

NeuBase Therapeutics to Present New Preclinical Data for Myotonic Dystrophy Type 1 Program at the 2022 MDA Clinical & Scientific Conference

Feb 10, 2022 7:00pm EST

NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2022

Jan 10, 2022 4:02pm EST

NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer

Jan 05, 2022 4:02pm EST

NeuBase Therapeutics Appoints Dr. Eric J. Ende to Board of Directors

Dec 23, 2021 4:01pm EST

NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021

Nov 03, 2021 4:05pm EDT

NeuBase to Present at the Jefferies London Healthcare Conference

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Neubase

NeuBase Therapeutics, Inc.
350 Technology Drive
Pittsburgh, PA 15219

info@neubasetherapeutics.com

Sign up for news

©2022 NeuBase Therapeutics, Inc. All rights reserved.

Privacy Policy|Terms of Use